Free Trial

CVS Health Corporation (NYSE:CVS) Shares Sold by Trust Co. of Vermont

CVS Health logo with Medical background

Trust Co. of Vermont trimmed its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 31.3% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 43,645 shares of the pharmacy operator's stock after selling 19,847 shares during the period. Trust Co. of Vermont's holdings in CVS Health were worth $2,957,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in CVS. Norges Bank acquired a new position in shares of CVS Health during the 4th quarter worth approximately $839,574,000. Capital World Investors increased its position in CVS Health by 26.6% during the fourth quarter. Capital World Investors now owns 61,039,777 shares of the pharmacy operator's stock worth $2,739,927,000 after buying an additional 12,819,148 shares in the last quarter. Davis Selected Advisers raised its holdings in shares of CVS Health by 2,998.1% in the fourth quarter. Davis Selected Advisers now owns 11,385,950 shares of the pharmacy operator's stock worth $511,115,000 after acquiring an additional 11,018,438 shares during the last quarter. Dodge & Cox boosted its stake in shares of CVS Health by 11.2% during the fourth quarter. Dodge & Cox now owns 70,105,899 shares of the pharmacy operator's stock valued at $3,147,054,000 after acquiring an additional 7,075,209 shares during the last quarter. Finally, Pzena Investment Management LLC increased its position in CVS Health by 49.3% during the 4th quarter. Pzena Investment Management LLC now owns 19,610,579 shares of the pharmacy operator's stock worth $880,319,000 after purchasing an additional 6,475,271 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Guy P. Sansone purchased 1,570 shares of the company's stock in a transaction that occurred on Thursday, June 5th. The shares were purchased at an average price of $63.70 per share, with a total value of $100,009.00. Following the purchase, the director now directly owns 12,007 shares of the company's stock, valued at approximately $764,845.90. This represents a 15.04% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 1.22% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the stock. Barclays set a $79.00 target price on shares of CVS Health and gave the company an "overweight" rating in a report on Monday, June 2nd. Wall Street Zen raised shares of CVS Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Robert W. Baird lifted their target price on shares of CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 15th. Jefferies Financial Group increased their price target on CVS Health from $74.00 to $80.00 and gave the stock a "buy" rating in a research note on Monday. Finally, Mizuho raised their price objective on CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Two investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, CVS Health currently has an average rating of "Moderate Buy" and an average target price of $75.06.

Get Our Latest Stock Analysis on CVS Health

CVS Health Trading Up 0.6%

NYSE CVS traded up $0.42 during mid-day trading on Monday, hitting $68.91. The company's stock had a trading volume of 3,599,721 shares, compared to its average volume of 10,426,735. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.82 and a quick ratio of 0.63. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $72.51. The stock's fifty day simple moving average is $64.86 and its two-hundred day simple moving average is $60.93. The firm has a market capitalization of $87.17 billion, a P/E ratio of 16.45, a price-to-earnings-growth ratio of 0.98 and a beta of 0.56.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.63. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. During the same quarter in the previous year, the business posted $1.31 EPS. The business's quarterly revenue was up 7.0% on a year-over-year basis. Research analysts expect that CVS Health Corporation will post 5.89 EPS for the current year.

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Featured Stories

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Should You Invest $1,000 in CVS Health Right Now?

Before you consider CVS Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.

While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines